Frequency of Extracorporeal Membrane Oxygenation Support and Outcomes After Implementation of a Structured PICU Network in Neonates and Children: A Prospective Population-Based Study in the West of France

CONCLUSIONS: Our local results suggest that a structured referral network for neonatal and pediatric ECMO in the region of Western France facilitated escalation of care with noninferior (or similar) early mortality outcome. Our data support establishing referral networks in other equivalent regions.
Source: Pediatric Critical Care Medicine - Category: Pediatrics Tags: Online Clinical Investigations Source Type: research

Related Links:

CONCLUSION: What we can retain from our case is that SMA can be the cause or consequence of coronary ischemia, so we must be vigilant in patients with an atypical clinical presentation.PMID:34868571 | PMC:PMC8626648 | DOI:10.1016/j.amsu.2021.103042
Source: Annals of Medicine - Category: Internal Medicine Authors: Source Type: research
Source: European Journal of Heart Failure - Category: Cardiology Authors: Tags: INTRODUCTION Source Type: research
Spontaneous coronary artery dissection (SCAD) is a nonatherosclerotic cause of myocardial infarction.1 Unlike atherosclerosis,2 treating patients with SCAD with percutaneous coronary intervention (PCI) is not associated with better outcomes.3 Because conservative therapy is preferred, its role in those presenting with ST-elevation myocardial infarction (STEMI) involving left main (LM) or proximal left anterior descending (LAD) arteries or with cardiogenic shock remains undefined. Therefore, we used the Nationwide Readmission Database (NRD) to explore the outcomes of SCAD causing STEMI, stratified by the coronary artery inv...
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Kardiol Pol. 2021 Dec 3. doi: 10.33963/KP.a2021.0169. Online ahead of print.ABSTRACTMechanical circulatory support (MCS) methods are used in patients with both acute and chronic heart failure, who have depleted the options for pharmacological or surgical treatment. The purpose of their use is to partially or completely support the failure ventricles and ensure adequate organ perfusion, which allows patients to restore full cardiovascular capacity, prolonging life and effectively improving its quality. Three most popular devices include intra-aortic balloon pump (IABP), percutaneous assist devices (including Impella, Tandem...
Source: Polish Heart Journal - Category: Cardiology Authors: Source Type: research
We present the case of a 37-year-old male who admitted to our hospital with fever, weakness, limb pain for 6 days and dyspnea for 14 hours .The patient had no immune related diseases.He was rapidly diagnosed with fulminant myocarditis and progressed to severe cardiogenic shock during the early stage.Then he was treated with V-A extracorporeal membrane oxygenation (ECMO). It is worth mentioning that the patient's peripheral blood was taken for metagenomic Next-Generation Sequencing(mNGS) upon admission and the results did not find any pathogenic bacteria.But there is no further examination(such as coronary angiography and m...
Source: Revista Espanola de Enfermedades Digestivas - Category: Gastroenterology Authors: Source Type: research
South Med J. 2021 Dec;114(12):751-759. doi: 10.14423/SMJ.0000000000001337.ABSTRACTCoronavirus disease 2019 (COVID-19) is an infection caused by the severe acute respiratory syndrome-coronavirus-2 virus that led to a pandemic. Acute manifestations of COVID-19 include fever, cough, dyspnea, respiratory failure, pneumonitis, anosmia, thromboembolic events, cardiogenic shock, renal injury, ischemic strokes, encephalitis, and cutaneous eruptions, especially of hands or feet. Prolonged symptoms, unpredictable recoveries, and chronic sequelae (long COVID) sometimes emerge even for some people who survive the initial illness. Sequ...
Source: Southern Medical Journal - Category: General Medicine Authors: Source Type: research
CONCLUSION: It is essential to demarcate COVID-19 infection and myocarditis presentations due to the heightened risk of death among patients contracting both myocardial inflammation and ARDS. With a multitude of diagnostic and treatment options available for COVID-19 and myocarditis, patients that are under high risk of suspicion for COVID-19 induced myocarditis must be appropriately diagnosed and treated to curb co-infections.PMID:34854348 | DOI:10.1177/21501327211056800
Source: Primary Care - Category: Primary Care Authors: Source Type: research
South Med J. 2021 Dec;114(12):751-759. doi: 10.14423/SMJ.0000000000001337.ABSTRACTCoronavirus disease 2019 (COVID-19) is an infection caused by the severe acute respiratory syndrome-coronavirus-2 virus that led to a pandemic. Acute manifestations of COVID-19 include fever, cough, dyspnea, respiratory failure, pneumonitis, anosmia, thromboembolic events, cardiogenic shock, renal injury, ischemic strokes, encephalitis, and cutaneous eruptions, especially of hands or feet. Prolonged symptoms, unpredictable recoveries, and chronic sequelae (long COVID) sometimes emerge even for some people who survive the initial illness. Sequ...
Source: Southern Medical Journal - Category: General Medicine Authors: Source Type: research
Int Heart J. 2021;62(6):1420-1429. doi: 10.1536/ihj.21-283.ABSTRACTLeft ventricular noncompaction cardiomyopathy (LVNC) is a heart muscle disorder morphologically characterized by reticulated trabeculations and intertrabecular recesses in the left ventricular (LV) cavity. LVNC is a genetically and phenotypically heterogeneous condition, which has been increasingly recognized with the accumulation of evidence provided by genotype-phenotype correlation analyses. Here, we report 2 sporadic adult cases of LVNC; both developed acute heart failure as an initial clinical manifestation and harbored causal sarcomere gene mutations....
Source: International Heart Journal - Category: Cardiology Authors: Source Type: research
CONCLUSION: It is essential to demarcate COVID-19 infection and myocarditis presentations due to the heightened risk of death among patients contracting both myocardial inflammation and ARDS. With a multitude of diagnostic and treatment options available for COVID-19 and myocarditis, patients that are under high risk of suspicion for COVID-19 induced myocarditis must be appropriately diagnosed and treated to curb co-infections.PMID:34854348 | DOI:10.1177/21501327211056800
Source: Primary Care - Category: Primary Care Authors: Source Type: research
More News: Cardiogenic Shock | Cardiology | Children | France Health | Heart | Pediatrics | Perinatology & Neonatology | Respiratory Medicine | Study